CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer

Conclusion: CDK1 was involved in the pathogenesis of endometrioid endometrial cancer and provided a novel therapeutic target for endometrioid endometrial cancer.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Xue Ying, Xuan Che, Jianzhang Wang, Gen Zou, Qin Yu, Xinmei Zhang Tags: Research Paper Source Type: research